跳至主要内容
临床试验/EUCTR2011-001659-36-IT
EUCTR2011-001659-36-IT进行中(未招募)不适用

ABCB1/P-glycoprotein as biological marker for treatment of patient with high grade osteosarcoma - ISG/OS-2

ITALIAN SARCOMA GROUP0 个研究点目标入组 225 人开始时间: 2011年9月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
225

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Histology confirmed diagnosis of extremities high grade osteosarcoma,
  • Age = 40 years, Localized disease or presence of skip metastasis, Epatic, renal and bone marrow normal function,
  • LVEF > 50%, No previous surgery and/ or chemotherapic osteosarcoma treatments, No more than 4 weeks interval between histological diagnosis and start of chemotherapy,
  • Informed consent to the study participation obtained.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 146
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 79
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Presence of metastases other than skip metastases, Periosteal Osteosarcoma, parostal osteosarcoma, secondary osteosarcoma, Medical contra-indication to the drugs foreseen in the protocol, Subject is pregnant or breast feeding.

研究者

相似试验

se of biological marker (ABCB1/P-glycoprotein) as... | 临床试验